Tag: Cybin Corp.

November 6, 2020

Cybin Completes Reverse Take-Over Transaction

Common Shares Expected to Commence Trading on the NEO Exchange on or about November 10, 2020 
October 19, 2020

Cybin and Clarmin Announce Closing of CDN$45 Million Oversubscribed Private Placement and Provide Update on RTO

CLARMIN EXPLORATIONS INC. (TSXV: CX.V) and CYBIN CORP. announce the closing of a private placement offering by the Company (the...
August 31, 2020

Former Actavis Head Of M&A Joins Psychedelics Company As CEO

Drysdale will serve as CEO, bringing to the table more than 3 decades of experience in the health care sector.
August 19, 2020

Cybin Corp: Developing Psychedelic Medicines and Nutraceutical Products

Cybin Corp is a life science company developing mushroom-based psychedelic pharmaceuticals and non-psychedelic nutraceutical products.
August 7, 2020

Cybin Applauds TheraPsil’s Advocacy to Bring Psilocybin Therapy to Palliative Care of Canadian Patients

Cybin Corp. applauds the efforts of TheraPsil, a non-profit coalition that advocates for legal, Special Access Programme (SAP) access to...
July 21, 2020

Cybin Corp. Announces Proposed Management Team and Board of Directors of the Resulting Issuer

Cybin Corp. (“Cybin” or the “Company”), a private psilocybin and nutraceutical company is pleased to announce the proposed management team...
July 16, 2020

Clarmin Explorations Inc. Announces Proposed Management Team and Board of Directors of the Resulting Issuer

Clarmin Explorations Inc. (TSX.V: CX) announces the proposed management team and board of directors of the issuer resulting from the...